Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/150443
Full metadata record
DC FieldValueLanguage
dc.creatorCavadas, B
dc.creatorLeite, M
dc.creatorPedro, N
dc.creatorMagalhães, AC
dc.creatorMelo, J
dc.creatorCorreia, M
dc.creatorMáximo, V
dc.creatorCamacho, R
dc.creatorFonseca, NA
dc.creatorFigueiredo, C
dc.creatorPereira, L
dc.date.accessioned2023-06-27T13:24:30Z-
dc.date.available2023-06-27T13:24:30Z-
dc.date.issued2021
dc.identifier.issn2076-2607
dc.identifier.urihttps://hdl.handle.net/10216/150443-
dc.description.abstractThe continuous characterization of genome-wide diversity in population and case- cohort samples, allied to the development of new algorithms, are shedding light on host ancestry impact and selection events on various infectious diseases. Especially interesting are the longstanding associations between humans and certain bacteria, such as the case of Helicobacter pylori, which could have been strong drivers of adaptation leading to coevolution. Some evidence on admixed gastric cancer cohorts have been suggested as supporting Homo-Helicobacter coevolution, but reliable experimental data that control both the bacterium and the host ancestries are lacking. Here, we conducted the first in vitro coinfection assays with dual humanand bacterium-matched and -mismatched ancestries, in African and European backgrounds, to evaluate the genome wide gene expression host response to H. pylori. Our results showed that: (1) the host response to H. pylori infection was greatly shaped by the human ancestry, with variability on innate immune system and metabolism; (2) African human ancestry showed signs of coevolution with H. pylori while European ancestry appeared to be maladapted; and (3) mismatched ancestry did not seem to be an important differentiator of gene expression at the initial stages of infection as assayed here.
dc.description.sponsorshipFunds were guaranteed by the project “Advancing cancer research: from basic knowledge to application”; NORTE-01-0145-FEDER-000029; Projetos Estruturados de I & D & I, funded by Norte 2020-Programa Operacional Regional do Norte. i3S is financed by FEDER-Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020-Competitiveness and Internationalization Operational Programme (POCI), Portugal 2020, and by Portuguese funds through FCT/Ministério da Ciência, Tecnologia e Inovação in the framework of the project “Institute for Research and Innovation in Health Sciences” (POCI-01-0145-FEDER-007274).
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofMicroorganisms, vol.9(2):240
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleShedding light on the african enigma: In vitro testing of homo sapiens-helicobacter pylori coevolution
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde
dc.identifier.doi10.3390/microorganisms9020240
dc.relation.publisherversionhttps://www.mdpi.com/2076-2607/9/2/240
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
10.3390-microorganisms9020240.pdf4.05 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons